{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T09:47:36Z","timestamp":1774691256243,"version":"3.50.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T00:00:00Z","timestamp":1677801600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T00:00:00Z","timestamp":1677801600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Key R&D Guidance Plan Projects in Liaoning Province","award":["2020JH1\/10300001"],"award-info":[{"award-number":["2020JH1\/10300001"]}]},{"DOI":"10.13039\/501100015226","name":"Shengjing Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015226","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1007\/s10875-023-01456-0","type":"journal-article","created":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T14:02:56Z","timestamp":1677852176000},"page":"979-988","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["A Case Report of IPEX Syndrome with Neonatal Diabetes Mellitus and Congenital Hypothyroidism as the Initial Presentation, and a Systematic Review of neonatal IPEX"],"prefix":"10.1007","volume":"43","author":[{"given":"A-na","family":"Hou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8531-4281","authenticated-orcid":false,"given":"Yu-qing","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,3,3]]},"reference":[{"key":"1456_CR1","doi-asserted-by":"publisher","first-page":"594375","DOI":"10.3389\/fped.2020.594375","volume":"8","author":"RK Mailer","year":"2020","unstructured":"Mailer RK. IPEX as a Consequence of Alternatively Spliced FOXP3. Front Pediatr. 2020;8:594375.","journal-title":"Front Pediatr"},{"issue":"29","key":"1456_CR2","doi-asserted-by":"publisher","first-page":"4121","DOI":"10.1038\/onc.2010.174","volume":"29","author":"F Martin","year":"2010","unstructured":"Martin F, et al. Human FOXP3 and cancer. Oncogene. 2010;29(29):4121\u20139.","journal-title":"Oncogene"},{"issue":"1","key":"1456_CR3","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/83713","volume":"27","author":"CL Bennett","year":"2001","unstructured":"Bennett CL, et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet. 2001;27(1):20\u20131.","journal-title":"Nat Genet"},{"issue":"5","key":"1456_CR4","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1136\/jmedgenet-2012-100759","volume":"49","author":"E d'Hennezel","year":"2012","unstructured":"d\u2019Hennezel E, et al. The immunogenetics of immune dysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome. J Med Genet. 2012;49(5):291\u2013302.","journal-title":"J Med Genet"},{"issue":"6","key":"1456_CR5","doi-asserted-by":"publisher","first-page":"e221","DOI":"10.1111\/pde.12126","volume":"30","author":"A Martin-Santiago","year":"2013","unstructured":"Martin-Santiago A, et al. Diagnostic value of the skin lesions in immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome. Pediatr Dermatol. 2013;30(6):e221\u20132.","journal-title":"Pediatr Dermatol"},{"key":"1456_CR6","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3389\/fped.2017.00267","volume":"5","author":"T Ge","year":"2017","unstructured":"Ge T, et al. Atypical Late-Onset Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked Syndrome with Intractable Diarrhea: A Case Report. Front Pediatr. 2017;5:267.","journal-title":"Front Pediatr"},{"issue":"7","key":"1456_CR7","first-page":"790","volume":"22","author":"GM Chu","year":"2020","unstructured":"Chu GM, et al. Variant analysis on steroid 5-reductase type 2 deficiency caused by a novel SRD5A2 mutation. Zhongguo Dang Dai Er Ke Za Zhi. 2020;22(7):790\u20135.","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"key":"1456_CR8","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13039-020-00494-2","volume":"13","author":"T Li","year":"2020","unstructured":"Li T, et al. Genotype-phenotype correlation in 75 patients with small supernumerary marker chromosomes. Mol Cytogenet. 2020;13:30.","journal-title":"Mol Cytogenet"},{"issue":"3","key":"1456_CR9","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1111\/cge.13789","volume":"98","author":"EN Suspitsin","year":"2020","unstructured":"Suspitsin EN, et al. Next generation sequencing analysis of consecutive Russian patients with clinical suspicion of inborn errors of immunity. Clin Genet. 2020;98(3):231\u20139.","journal-title":"Clin Genet"},{"issue":"8","key":"1456_CR10","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1002\/ccr3.1070","volume":"5","author":"SB Kim","year":"2017","unstructured":"Kim SB, et al. Clinical description of a neonate carrying the largest reported deletion involving the 10p15.3p13 region. Clin Case Rep. 2017;5(8):1369\u201375.","journal-title":"Clin Case Rep"},{"issue":"1","key":"1456_CR11","doi-asserted-by":"publisher","first-page":"111","DOI":"10.2337\/dc08-1188","volume":"32","author":"O Rubio-Cabezas","year":"2009","unstructured":"Rubio-Cabezas O, et al. Clinical heterogeneity in patients with FOXP3 mutations presenting with permanent neonatal diabetes. Diabetes Care. 2009;32(1):111\u20136.","journal-title":"Diabetes Care"},{"issue":"4","key":"1456_CR12","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1067\/mpd.2001.111502","volume":"138","author":"E Levy-Lahad","year":"2001","unstructured":"Levy-Lahad E, Wildin RS. Neonatal diabetes mellitus, enteropathy, thrombocytopenia, and endocrinopathy: Further evidence for an X-linked lethal syndrome. J Pediatr. 2001;138(4):577\u201380.","journal-title":"J Pediatr"},{"issue":"2","key":"1456_CR13","doi-asserted-by":"publisher","first-page":"e59","DOI":"10.1111\/ped.12570","volume":"57","author":"E Park","year":"2015","unstructured":"Park E, et al. Familial IPEX syndrome: different glomerulopathy in two siblings. Pediatr Int. 2015;57(2):e59-61.","journal-title":"Pediatr Int"},{"issue":"4","key":"1456_CR14","doi-asserted-by":"publisher","first-page":"e43","DOI":"10.1016\/j.clinre.2015.03.006","volume":"39","author":"R Duclaux-Loras","year":"2015","unstructured":"Duclaux-Loras R, et al. Long-term disease course in a patient with severe neonatal IPEX syndrome. Clin Res Hepatol Gastroenterol. 2015;39(4):e43\u20137.","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"2","key":"1456_CR15","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.clim.2014.12.007","volume":"156","author":"MM Xavier-da-Silva","year":"2015","unstructured":"Xavier-da-Silva MM, et al. Fetal-onset IPEX: report of two families and review of literature. Clin Immunol. 2015;156(2):131\u201340.","journal-title":"Clin Immunol"},{"issue":"2","key":"1456_CR16","doi-asserted-by":"publisher","first-page":"98","DOI":"10.2350\/06-07-0130.1","volume":"10","author":"ML Heltzer","year":"2007","unstructured":"Heltzer ML, et al. A potential screening tool for IPEX syndrome. Pediatr Dev Pathol. 2007;10(2):98\u2013105.","journal-title":"Pediatr Dev Pathol"},{"issue":"6","key":"1456_CR17","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s10875-014-0059-7","volume":"34","author":"S Baris","year":"2014","unstructured":"Baris S, et al. Clinical heterogeneity of immunodysregulation, polyendocrinopathy, enteropathy, X-linked: pulmonary involvement as a non-classical disease manifestation. J Clin Immunol. 2014;34(6):601\u20136.","journal-title":"J Clin Immunol"},{"issue":"9\u201310","key":"1456_CR18","doi-asserted-by":"publisher","first-page":"538","DOI":"10.2298\/SARH0810538R","volume":"136","author":"N Radlovic","year":"2008","unstructured":"Radlovic N, et al. IPEX syndrome\u2013case report. Srp Arh Celok Lek. 2008;136(9\u201310):538\u201341.","journal-title":"Srp Arh Celok Lek"},{"issue":"5","key":"1456_CR19","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s10875-008-9196-1","volume":"28","author":"PL Yong","year":"2008","unstructured":"Yong PL, Russo P, Sullivan KE. Use of sirolimus in IPEX and IPEX-like children. J Clin Immunol. 2008;28(5):581\u20137.","journal-title":"J Clin Immunol"},{"issue":"23","key":"1456_CR20","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1056\/NEJM200106073442304","volume":"344","author":"O Baud","year":"2001","unstructured":"Baud O, et al. Treatment of the immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) by allogeneic bone marrow transplantation. N Engl J Med. 2001;344(23):1758\u201362.","journal-title":"N Engl J Med"},{"issue":"10","key":"1456_CR21","doi-asserted-by":"publisher","first-page":"3979","DOI":"10.1210\/jc.2007-0486","volume":"92","author":"S Suzuki","year":"2007","unstructured":"Suzuki S, et al. Molecular basis of neonatal diabetes in Japanese patients. J Clin Endocrinol Metab. 2007;92(10):3979\u201385.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1456_CR22","doi-asserted-by":"publisher","first-page":"e74","DOI":"10.1111\/pde.12550","volume":"32","author":"S Bis","year":"2015","unstructured":"Bis S, et al. Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome associated with neonatal epidermolysis bullosa acquisita. Pediatr Dermatol. 2015;32(3):e74\u20137.","journal-title":"Pediatr Dermatol"},{"key":"1456_CR23","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3389\/fped.2019.00020","volume":"7","author":"C Agakidis","year":"2019","unstructured":"Agakidis C, et al. Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked Syndrome Associated With a Novel Mutation of FOXP3 Gene. Front Pediatr. 2019;7:20.","journal-title":"Front Pediatr"},{"issue":"1","key":"1456_CR24","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1136\/adc.2005.078287","volume":"91","author":"AK Myers","year":"2006","unstructured":"Myers AK, et al. Clinical and molecular findings in IPEX syndrome. Arch Dis Child. 2006;91(1):63\u20134.","journal-title":"Arch Dis Child"},{"issue":"3","key":"1456_CR25","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1111\/j.1365-3083.2011.02574.x","volume":"74","author":"YF An","year":"2011","unstructured":"An YF, et al. Clinical and molecular characteristics of immunodysregulation, polyendocrinopathy, enteropathy, X-linked syndrome in China. Scand J Immunol. 2011;74(3):304\u20139.","journal-title":"Scand J Immunol"},{"issue":"3","key":"1456_CR26","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1053\/j.gastro.2010.06.006","volume":"139","author":"N Moes","year":"2010","unstructured":"Moes N, et al. Reduced expression of FOXP3 and regulatory T-cell function in severe forms of early-onset autoimmune enteropathy. Gastroenterology. 2010;139(3):770\u20138.","journal-title":"Gastroenterology"},{"issue":"6","key":"1456_CR27","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/j.jaci.2008.09.027","volume":"122","author":"E Gambineri","year":"2008","unstructured":"Gambineri E, et al. Clinical and molecular profile of a new series of patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome: inconsistent correlation between forkhead box protein 3 expression and disease severity. J Allergy Clin Immunol. 2008;122(6):1105\u201312 (e1).","journal-title":"J Allergy Clin Immunol."},{"issue":"8","key":"1456_CR28","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1136\/jmg.39.8.537","volume":"39","author":"RS Wildin","year":"2002","unstructured":"Wildin RS, Smyk-Pearson S, Filipovich AH. Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome. J Med Genet. 2002;39(8):537\u201345.","journal-title":"J Med Genet"},{"issue":"3","key":"1456_CR29","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.jaut.2010.06.017","volume":"35","author":"M Tsuda","year":"2010","unstructured":"Tsuda M, et al. The spectrum of autoantibodies in IPEX syndrome is broad and includes anti-mitochondrial autoantibodies. J Autoimmun. 2010;35(3):265\u20138.","journal-title":"J Autoimmun"},{"issue":"12","key":"1456_CR30","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1136\/jmg.38.12.874","volume":"38","author":"I Kobayashi","year":"2001","unstructured":"Kobayashi I, et al. Novel mutations of FOXP3 in two Japanese patients with immune dysregulation, polyendocrinopathy, enteropathy, X linked syndrome (IPEX). J Med Genet. 2001;38(12):874\u20136.","journal-title":"J Med Genet"},{"issue":"3","key":"1456_CR31","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.clim.2007.08.004","volume":"125","author":"T Fuchizawa","year":"2007","unstructured":"Fuchizawa T, et al. Developmental changes of FOXP3-expressing CD4+CD25+ regulatory T cells and their impairment in patients with FOXP3 gene mutations. Clin Immunol. 2007;125(3):237\u201346.","journal-title":"Clin Immunol"},{"issue":"11","key":"1456_CR32","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1002\/pd.2613","volume":"30","author":"R Harbuz","year":"2010","unstructured":"Harbuz R, et al. Identification of new FOXP3 mutations and prenatal diagnosis of IPEX syndrome. Prenat Diagn. 2010;30(11):1072\u20138.","journal-title":"Prenat Diagn"},{"issue":"5","key":"1456_CR33","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1002\/ajmg.a.38144","volume":"173","author":"RJ Louie","year":"2017","unstructured":"Louie RJ, et al. Novel pathogenic variants in FOXP3 in fetuses with echogenic bowel and skin desquamation identified by ultrasound. Am J Med Genet A. 2017;173(5):1219\u201325.","journal-title":"Am J Med Genet A"},{"key":"1456_CR34","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3389\/fped.2017.00037","volume":"5","author":"P Tuijnenburg","year":"2017","unstructured":"Tuijnenburg P, et al. Humoral Immunodeficiency with Hypotonia, Feeding Difficulties, Enteropathy, and Mild Eczema Caused by a Classical FOXP3 Mutation. Front Pediatr. 2017;5:37.","journal-title":"Front Pediatr"},{"key":"1456_CR35","unstructured":"Marquart, H., et al., IPEX without Dermatitis and Hyper-ige in an Indian Infant with FOXP3 A384T Mutation, in 15th Biennial Meeting European-Society-for-Immunodeficiency. 2012. J Clin Immunol."},{"key":"1456_CR36","unstructured":"Tantou S. et al. Novel Mutation of FOXP3 Gene to the First Reported Patient with Immunodysregulation, Polyendocrinopathy and Enteropathy X-Linked Syndrome in Greece, in 16th biennial meeting of the European society for immunodeficiencies. 2014: Prague, Czech Republic. p. S228-S229."},{"key":"1456_CR37","unstructured":"Cs\u00fcrke I. et al. The FOXP3 Gene Mutation in Infancy with Immune Dysregulation, Polyenocrinopathy, Enteropathy, X-Linked (IPEX) Syndrome in Hungary, in 16th biennial meeting of the European society for immunodeficiencies. 2014: Prague, Czech Republic. p. S206-S207."},{"issue":"17","key":"1456_CR38","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1056\/NEJMc0907093","volume":"361","author":"Eva d'Hennezel","year":"2009","unstructured":"Eva d\u2019Hennezel, et al. FOXP3 forkhead domain mutation and regulatory T cells in the IPEX syndrome. N Engl J Med. 2009;361(17):1710\u20133.","journal-title":"N Engl J Med"},{"key":"1456_CR39","unstructured":"Zhu Q. Screening for FOXP3 gene mutations in immune dysregylation, polyendocrinopathy, enteropathy, X-linked syndrome. In Medical School. 2018, Zhejiang University: Hangzhou, China."},{"issue":"8","key":"1456_CR40","first-page":"620","volume":"35","author":"XY He Tingyan","year":"2017","unstructured":"He Tingyan XY, et al. IPEX with congential ichthyosiform skin lesions: a case report and literature review. J Clin Pediatr. 2017;35(8):620\u20134.","journal-title":"J Clin Pediatr"},{"issue":"6","key":"1456_CR41","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.autrev.2005.12.002","volume":"5","author":"CH Wasserfall","year":"2006","unstructured":"Wasserfall CH, Atkinson MA. Autoantibody markers for the diagnosis and prediction of type 1 diabetes. Autoimmun Rev. 2006;5(6):424\u20138.","journal-title":"Autoimmun Rev"},{"issue":"2","key":"1456_CR42","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1055\/s-2004-822657","volume":"217","author":"FA Baumeister","year":"2005","unstructured":"Baumeister FA, Engelsberger I, Schulze A. Pancreatic agenesis as cause for neonatal diabetes mellitus. Klin Padiatr. 2005;217(2):76\u201381.","journal-title":"Klin Padiatr"},{"issue":"7","key":"1456_CR43","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.metabol.2006.05.021","volume":"56","author":"J Takada","year":"2007","unstructured":"Takada J, et al. Neonatal streptozotocin-induced diabetes mellitus: a model of insulin resistance associated with loss of adipose mass. Metabolism. 2007;56(7):977\u201384.","journal-title":"Metabolism"},{"issue":"6","key":"1456_CR44","doi-asserted-by":"publisher","first-page":"102526","DOI":"10.1016\/j.autrev.2020.102526","volume":"19","author":"JH Park","year":"2020","unstructured":"Park JH, et al. Immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome: A systematic review. Autoimmun Rev. 2020;19(6):102526.","journal-title":"Autoimmun Rev"},{"key":"1456_CR45","doi-asserted-by":"publisher","first-page":"599283","DOI":"10.3389\/fped.2020.599283","volume":"8","author":"M Carneiro-Sampaio","year":"2020","unstructured":"Carneiro-Sampaio M, et al. Intrauterine IPEX. Front Pediatr. 2020;8:599283.","journal-title":"Front Pediatr"},{"key":"1456_CR46","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/978-1-4419-1599-3_2","volume":"665","author":"CH Kim","year":"2009","unstructured":"Kim CH. FOXP3 and its role in the immune system. Adv Exp Med Biol. 2009;665:17\u201329.","journal-title":"Adv Exp Med Biol"},{"key":"1456_CR47","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jaut.2012.12.004","volume":"41","author":"H Katoh","year":"2013","unstructured":"Katoh H, Zheng P, Liu Y. FOXP3: genetic and epigenetic implications for autoimmunity. J Autoimmun. 2013;41:72\u20138.","journal-title":"J Autoimmun"},{"key":"1456_CR48","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.molimm.2022.10.017","volume":"152","author":"MF Cassidy","year":"2022","unstructured":"Cassidy MF, Herbert ZT, Moulton VR. Splicing factor SRSF1 controls autoimmune-related molecular pathways in regulatory T cells distinct from FoxP3. Mol Immunol. 2022;152:140\u201352.","journal-title":"Mol Immunol"},{"issue":"2","key":"1456_CR49","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.immuni.2017.07.008","volume":"47","author":"N Hayatsu","year":"2017","unstructured":"Hayatsu N, et al. Analyses of a Mutant Foxp3 Allele Reveal BATF as a Critical Transcription Factor in the Differentiation and Accumulation of Tissue Regulatory T Cells. Immunity. 2017;47(2):268\u201383 (e9).","journal-title":"Immunity"},{"issue":"2","key":"1456_CR50","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.immuni.2018.12.016","volume":"50","author":"F Van Gool","year":"2019","unstructured":"Van Gool F, et al. A Mutation in the Transcription Factor Foxp3 Drives T Helper 2 Effector Function in Regulatory T Cells. Immunity. 2019;50(2):362\u201377 (e6).","journal-title":"Immunity"},{"issue":"1","key":"1456_CR51","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.jaci.2019.03.003","volume":"144","author":"K Frith","year":"2019","unstructured":"Frith K, et al. The FOXP3Delta2 isoform supports Treg cell development and protects against severe IPEX syndrome. J Allergy Clin Immunol. 2019;144(1):317\u201320 (e8).","journal-title":"J Allergy Clin Immunol"},{"issue":"8","key":"1456_CR52","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1084\/jem.20050157","volume":"202","author":"X Chang","year":"2005","unstructured":"Chang X, et al. The Scurfy mutation of FoxP3 in the thymus stroma leads to defective thymopoiesis. J Exp Med. 2005;202(8):1141\u201351.","journal-title":"J Exp Med"},{"issue":"53","key":"1456_CR53","first-page":"322","volume":"10","author":"L Wang","year":"2010","unstructured":"Wang L, et al. FOXP3 as an X-linked tumor suppressor. Discov Med. 2010;10(53):322\u20138.","journal-title":"Discov Med"},{"issue":"1","key":"1456_CR54","doi-asserted-by":"publisher","first-page":"e10","DOI":"10.1016\/j.leukres.2010.09.008","volume":"35","author":"MS Kim","year":"2011","unstructured":"Kim MS, et al. No mutation in the FOXP3 gene in acute leukemias. Leuk Res. 2011;35(1):e10.","journal-title":"Leuk Res"},{"issue":"3","key":"1456_CR55","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1111\/j.1365-2133.2008.08835.x","volume":"160","author":"M Halabi-Tawil","year":"2009","unstructured":"Halabi-Tawil M, et al. Cutaneous manifestations of immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome. Br J Dermatol. 2009;160(3):645\u201351.","journal-title":"Br J Dermatol"},{"issue":"1","key":"1456_CR56","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/nyas.13011","volume":"1417","author":"R Bacchetta","year":"2018","unstructured":"Bacchetta R, Barzaghi F, Roncarolo MG. From IPEX syndrome to FOXP3 mutation: a lesson on immune dysregulation. Ann N Y Acad Sci. 2018;1417(1):5\u201322.","journal-title":"Ann N Y Acad Sci"},{"key":"1456_CR57","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3389\/fimmu.2012.00211","volume":"3","author":"F Barzaghi","year":"2012","unstructured":"Barzaghi F, Passerini L, Bacchetta R. Immune dysregulation, polyendocrinopathy, enteropathy, x-linked syndrome: a paradigm of immunodeficiency with autoimmunity. Front Immunol. 2012;3:211.","journal-title":"Front Immunol"},{"issue":"3","key":"1456_CR58","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.jaci.2017.10.041","volume":"141","author":"F Barzaghi","year":"2018","unstructured":"Barzaghi F, et al. Long-term follow-up of IPEX syndrome patients after different therapeutic strategies: An international multicenter retrospective study. J Allergy Clin Immunol. 2018;141(3):1036\u201349 (e5).","journal-title":"J Allergy Clin Immunol"},{"key":"1456_CR59","doi-asserted-by":"publisher","first-page":"910021","DOI":"10.3389\/fimmu.2022.910021","volume":"13","author":"F Barzaghi","year":"2022","unstructured":"Barzaghi F, et al. Case Report: Consistent disease manifestations with a staggered time course in two identical twins affected by adenosine deaminase 2 deficiency. Front Immunol. 2022;13:910021.","journal-title":"Front Immunol"},{"key":"1456_CR60","doi-asserted-by":"publisher","first-page":"2767","DOI":"10.3389\/fimmu.2018.02767","volume":"9","author":"F Barzaghi","year":"2018","unstructured":"Barzaghi F, et al. ALPS-Like Phenotype Caused by ADA2 Deficiency Rescued by Allogeneic Hematopoietic Stem Cell Transplantation. Front Immunol. 2018;9:2767.","journal-title":"Front Immunol"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-023-01456-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-023-01456-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-023-01456-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T08:12:34Z","timestamp":1686903154000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-023-01456-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,3]]},"references-count":60,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["1456"],"URL":"https:\/\/doi.org\/10.1007\/s10875-023-01456-0","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,3]]},"assertion":[{"value":"25 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"This study was approved by the ethics committee of Shengjing Hospital of China Medical University (2021PS682K).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval Statement"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"The authors have agreed to publication.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}]}}